• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Pathol . ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS

tetano

Editor, Senior Moderator
Am J Pathol


. 2020 Jul 3;S0002-9440(20)30328-X.
doi: 10.1016/j.ajpath.2020.07.001. Online ahead of print.
ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS


Kimon V Argyropoulos[SUP] 1 [/SUP], Antonio Serrano[SUP] 1 [/SUP], Jiyuan Hu[SUP] 2 [/SUP], Margaret Black[SUP] 1 [/SUP], Xiaojun Feng[SUP] 1 [/SUP], Guomiao Shen[SUP] 1 [/SUP], Melissa Call[SUP] 3 [/SUP], Min Jae Kim[SUP] 3 [/SUP], Andrew Lytle[SUP] 1 [/SUP], Brendan Belovarac[SUP] 1 [/SUP], Theodore Vougiouklakis[SUP] 1 [/SUP], Lawrence Hsu Lin[SUP] 1 [/SUP], Una Moran[SUP] 4 [/SUP], Adriana Heguy[SUP] 1 [/SUP], Andrea Troxel[SUP] 2 [/SUP], Matija Snuderl[SUP] 1 [/SUP], Iman Osman[SUP] 5 [/SUP], Paolo Cotzia[SUP] 6 [/SUP], George Jour[SUP] 7 [/SUP]



Affiliations

Abstract

The dynamics of viral load (VL) of the 2019 novel coronavirus (SARS-CoV-2) and its association with different clinical parameters remain poorly characterized in the United States patient population. Herein we investigate associations between VL and parameters such as severity of symptoms, disposition (admission vs direct discharge), length of hospitalization, and admission to the intensive care unit, length of need for oxygen support and overall survival in a cohort of 205 patients from a tertiary care center in New York City. VL was determined using q-PCR and Log10 transformed for normalization. Univariate and multivariate regression models were used to test these associations. We found that diagnostic viral load is significantly lower in hospitalized patients than in patients not hospitalized (log10 VL = 3.3 vs.4.0; p=0.018) after adjusting for age, sex, race, BMI, and comorbidities. Higher VL was associated with shorter duration of the symptoms in all patients and hospitalized patients only and shorter hospital stay (coefficient =-2.02,-2.61, -2.18; p<0.001, p=0.002, p=0.013, respectively). No significant association was noted between VL, admission to ICU, length of oxygen support, and overall survival. Our findings suggest a higher shedding risk in less symptomatic patients; an important consideration for containment strategies in SARS-CoV-2. Furthermore, we identify a novel association between viral load and history of cancer. Larger studies are warranted to validate our findings.

Keywords: COVID-19; Quantitative PCR; SARS-CoV-2; Viral Load.
 
Back
Top Bottom